Video

Q&A With Vincenzo La Mura From University of Milan: Applicability of Non-Selective Beta Blockers in the Elderly

Author(s):

A social problem with limited existing research, work has been done to understand the risks and benefits associated with administering non-selective beta blockers to elderly patients.

A social problem with limited existing research, Vincenzo La Mura, MD, University of Milan, and his colleagues hoped to understand the risks and benefits associated with administering non-selective beta blockers to elderly patients.

La Mura was one of the speakers when the European Association for the Study of the Liver held its 50th Annual Liver Conference in Vienna.

Related Videos
Experts' Perspectives: Top Stories in Cardiology for 2024
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Matthew Weir, MD: Prioritizing Cardiovascular Risk in Chronic Kidney Disease | Image Credit: University of Maryland
© 2024 MJH Life Sciences

All rights reserved.